Tue, Sep 16, 2014, 6:45 AM EDT - U.S. Markets open in 2 hrs 45 mins

Recent

% | $
Quotes you view appear here for quick access.

RAIT Financial Trust Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • davisfoulger davisfoulger Sep 13, 2010 3:15 PM Flag

    what is the chance?

    I'll take the "old days" as being the range RAS traded in for close to five years before the residential downturn turned into an economic calamity: e.g. $26-$30. I put the odds of seeing $9-$10 over the next two years at over 90%. There are good reasons for thinking that:

    1 - We'll be past the convertible notes put window. It will turn out to be a non-event.

    2 - Profitability will continue to improve such that the business can support a dividend.

    3 - The economy will improve enough that prices will start to rise again. RAS will sell some of its properties, turn the retained capital into new loans, and increase it profitability on loan turnover.

    4 - Financisls, including mortgage REITs, will move back into favor.

    That's just the high points.

    I rate the odds of the "dark side", as you put it, at less than 1%; the odds of an acquisition at less than 5%.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • " I put the odds of seeing $9-$10 over the next two years at over 90%. "

      But don't quote me on that. I'm also 90% certain that two years from now I'll deny that I ever said that, or anything remotely close to it.

      After all, I am perfectly happy to predict two years in the future. If anybody points to my prediction then, they'll just be 'dredging up old posts'. As we all know, that's not allowed.

 
RAS
7.71-0.05(-0.64%)Sep 15 4:05 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
21Vianet Group, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT